Hemodynamic and endocrine changes associated with captopril in diuretic-resistant hypertensive patients
- 1 September 1982
- journal article
- research article
- Published by Elsevier in The American Journal of Medicine
- Vol. 73 (3) , 341-347
- https://doi.org/10.1016/0002-9343(82)90724-0
Abstract
No abstract availableThis publication has 30 references indexed in Scilit:
- Angiotensin inhibition in severe heart failure: Acute central and limb hemodynamic effects of captopril with observations on sustained oral therapyAmerican Heart Journal, 1981
- Effects of angiotensin-converting enzyme inhibition on blood pressure and plasma renin activity in essential hypertensionAmerican Heart Journal, 1981
- Central and peripheral hemodynamic effects of angiotensin inhibition in patients with refractory congestive heart failure.Circulation, 1980
- Treatment of Chronic Congestive Heart Failure with Captopril, an Oral Inhibitor of Angiotensin-Converting EnzymeNew England Journal of Medicine, 1979
- Converting enzyme inhibition in essential hypertension: the hypotensive response does not reflect only reduced angiotensin II formation.Hypertension, 1979
- Angiotensin converting enzyme inhibition in patients with congestive heart failure.Circulation, 1978
- Role of the renin-angiotensin system in the systemic vasoconstriction of chronic congestive heart failure.Circulation, 1978
- Antihypertensive Effect of the Oral Angiotensin Converting-Enzyme Inhibitor SQ 14225 in ManNew England Journal of Medicine, 1978
- Accentuated Vascular and Endocrine Response to Sq 20881 in HypertensionNew England Journal of Medicine, 1977
- General Circulatory Alterations Induced by Intravenous Infusion of Synthetic Bradykinin in ManCirculation, 1964